当前位置：首页 > 文献互助 > 互助详情

Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities复制

用户AuN2r47E68qo 5个月前 196 10 已关闭

DOI:复制

文献链接:复制

其他信息:

上一篇：New Toxicity Signals Associated With Ixekizumab

下一篇：SonoPIN enables precise, noninvasive, and efficient intracellular delivery of PROTACs

互助时间线

2026-04-03 17:34:33 [关闭求助]

楼主用户AuN2r47E68qo关闭了求助

2026-04-03 15:23:05 [发起求助]

最新发布的求助

Microenvironment engineering of electrocatalysts for high-performance Zn-CO2 batteries 2小时前
The Principles of Equity 2小时前
GOLD stage 1 COPD requires precise intervention based on disease progression 3小时前
基于大语言模型改进的语义检索方法的应用研究 4小时前
基于大语言模型改进的语义检索方法的应用研究 4小时前
Gut microbiota dysbiosis in spinal cord injuries: immune impairment and therapeutic potential of microbiome modulation 4小时前
High prevalence of esophageal motility disorders in patients with rheumatologic diseases 6小时前
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer 6小时前
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non–Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART) 7小时前
Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study 7小时前
SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer 7小时前
Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE) 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com